P. Kakhsurueva, E. Kamyshova, I.N. Bobkova, E. Andreeva, O.A. Li
{"title":"原发性膜性肾病患者体内的 M 型磷脂酶 A2 受体抗体的临床意义","authors":"P. Kakhsurueva, E. Kamyshova, I.N. Bobkova, E. Andreeva, O.A. Li","doi":"10.32756/0869-5490-2023-4-45-50","DOIUrl":null,"url":null,"abstract":"To evaluate the significance of circulating antibodies to the M-type phospholipase A2 receptor (anti-PLA2R) in the diagnosis of primary membranous nephropathy (MN) and the determination of the clinical features of the disease.","PeriodicalId":10353,"journal":{"name":"Clinical pharmacology and therapy","volume":"9 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Clinical significance of antibodies to the M-type phospholipase A2 receptor in patients with primary membranous nephropathy\",\"authors\":\"P. Kakhsurueva, E. Kamyshova, I.N. Bobkova, E. Andreeva, O.A. Li\",\"doi\":\"10.32756/0869-5490-2023-4-45-50\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"To evaluate the significance of circulating antibodies to the M-type phospholipase A2 receptor (anti-PLA2R) in the diagnosis of primary membranous nephropathy (MN) and the determination of the clinical features of the disease.\",\"PeriodicalId\":10353,\"journal\":{\"name\":\"Clinical pharmacology and therapy\",\"volume\":\"9 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-11-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical pharmacology and therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.32756/0869-5490-2023-4-45-50\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical pharmacology and therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32756/0869-5490-2023-4-45-50","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
评估 M 型磷脂酶 A2 受体循环抗体（抗 PLA2R）在诊断原发性膜性肾病（MN）和确定该病临床特征方面的意义。
Clinical significance of antibodies to the M-type phospholipase A2 receptor in patients with primary membranous nephropathy
To evaluate the significance of circulating antibodies to the M-type phospholipase A2 receptor (anti-PLA2R) in the diagnosis of primary membranous nephropathy (MN) and the determination of the clinical features of the disease.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
